BioForward Member News

10Jun 2020

Read the full press release from Catalent here. Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has signed an agreement with Spicona, Inc. to develop a virus-like protein (VLP)-based vaccine against COVID-19. Under the terms […]

09Jun 2020

Read the full press release from Illumina here. Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. […]

05Jun 2020

Read the full story from the Wisconsin State Journal here. A Madison-based pharmaceutical developer looking to address the opioid crisis won the Wisconsin Governor’s Business Plan Contest Thursday. Plumb Pharmaceuticals, which is developing a drug delivery method that will help people battling opioid addiction, will receive cash and in-kind services for winning the grand prize […]

04Jun 2020

Read the full story from WISBUSINESS here. Virologists at the Morgridge Institute for Research are investigating the biology of viruses and their diseases in order to develop powerful new methods to not only control COVID-19 but stem the next pandemic. According to the institute, COVID-19 illustrates how viral threats are growing more common, underscoring the […]

03Jun 2020

Read the full press release from Eurofins here. Eurofins Technologies announces the launch of a serology-based total antibody (IgG, IgA and IgM) detection ELISA assay for indirect diagnostic of past exposure to COVID-19. The development of the assay has been led by Eurofins Ingenasa, a Eurofins Technologies company involved in the development of diagnostic tests […]

02Jun 2020

Read the full press release from the Wisconsin Alumni Research Foundation here. $100K fund to accelerate solutions being developed by UW–Madison researchers MADISON, Wis. – The Wisconsin Alumni Research Foundation announced that nine highly deployable projects have been selected to receive development funding through the UW/WARF COVID-19 Accelerator Challenge. From improved respirators to accelerated testing, […]

26May 2020

Read the full press release from Merck here. Merck (NYSE: MRK), known as MSD outside the United States and Canada, will today announce three significant scientific initiatives to combat COVID-19: two agreements to develop potential vaccines against SARS-CoV-2, and a research collaboration to advance the development of a novel antiviral candidate. Today’s announcements are: Merck […]